Buprenorphine dosing regime in the management of out-patient heroin withdrawal

Drug and Alcohol Review

Volumn 21, Issue 1, 2002, Pages 39-45

  Lintzeris, Nicholas ^a  

^a NONE   (Australia)

Author keywords

Buprenorphine; Detoxification; Dose regimes; Heroin withdrawal

Indexed keywords

BUPRENORPHINE;

ADULT; AMBULATORY CARE; ARTICLE; DRUG ADMINISTRATION; FEMALE; HEROIN DEPENDENCE; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; STATISTICS; WITHDRAWAL SYNDROME;

ADULT; AMBULATORY CARE; BUPRENORPHINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036004062     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595230220119309     Document Type: Article

References (29)

1. Mello N.K., Mendelson J.H. Buprenorphine suppresses heroin use by heroin addicts. Science 1980;207:657-9.
2. Jasinski D.R., et al. Progress report of the NIDA Addiction Research Centre, Baltimore, Maryland. In: Harris L.S., ed. Problems of drug dependence. NIDA research monograph series. Rockville, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1984:69-76.
3. Kosten T.R., Kleber H.D. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sci 1988; 42:635-41.
4. Bickel W.K., Stitzer M.L., Bigelow G.E., et al. Buprenorphine: dose related blockade of opioid challenge effects in opioid dependent humans. J Pharmacol Exp Ther 1988; 247:47-53.
5. Rosen M.I., et al. Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug Alcohol Depend 1994;35:141-9.
6. Cheskin L.J., Fudala P.J., Johnson R.E. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug Alcohol Depend 1994;36-115-21.
7. Kosten T.R., Morgan C. Kleber H.D. Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone. In: Blaine J.D. ed. Buprenorphine: an alternative treatment for opioid dependence. NIDA research monograph series. Rockville. MD: US Department of Health and Human Services, 1992:101-19.
8. Umbricht A., et al. Naltrexone shortened opioid detoxification with buprenorphine. Drug Alcohol Depend 1999;56:181-90.
9. Nigam A.K., Ray R., Tripathi M. Buprenorphine in opiate withdrawal: a comparison with clonidine. J Subst Abuse Treat 1993;10:391-4.
10. Schneider U., et al. Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study. Addict Biol 2000;5:65-9.
11. Liu Z.M., et al. Rapid detoxification of heroin dependence by buprenorphine. Chung Kuo Yao Li Hsueh Pao 1997; 18:112-14.
12. Vignau J. Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine. Eur Addict Res 1998;4:29-31.
13. O'Connor P., et al. Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Int Med 1997;127:526-30.
14. Diamant K., et al. Out-patient opiate detoxification treatment with buprenorphine. Eur Addict Res 1998;4: 198-202.
15. Nath R.P., et al. Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations. J Clin Pharmacol 1999;39:619-23.
16. Handelsman L., et al. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;13: 293-308.
17. Lintzeris N., Dunlop A., Thornton. D. Getting through heroin withdrawal: a guide for people trying to stop heroin use. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre; 1996:36.
18. Darke S., et al. Estimating drug consumption in opioid users: reliability and validity of a 'recent use' episodes method. Br J Addict 1991;86:1311-16.
19. Kosten T.R., et al. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis 1993;181:358-64.
20. Seow S.S., et al. Buprenorphine: a new maintenance opiate? Med J Aust 1986;144:407-11.
21. Schottenfeld R.S., et al. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry 1997;54:713-20.
22. Johnson R.E., et al. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend 1995;40:17-25.
23. Schottenfeld R.S., et al. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry 1993;34:66-74.
24. Kosten T.R., Kleber H.D. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sci 1988;42: 635-41.
25. Ling W., et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 1998;93:475-86.
26. Walsh S.L., et al. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994;55:569-80.
27. Walsh S.L., et al. Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther 1995;274:361-72.
28. Clark N.C., et al. A retrospective study of the use of short term methadone for heroin withdrawal. In: Australian Professional Society of Alcohol and Other Drugs, National Conference. Sydney, 1998.
29. Roethlisberger F.J., Dickson W.J. Management of the worker. Harvard: Harvard University Press, 1939.